Verified peer comparison
Neurocrine Biosciences vs Blue Owl Capital Financial Comparison
Direct answer
Neurocrine Biosciences and Blue Owl Capital are compared on the same basis.
The comparison uses 2025 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free Neurocrine Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Neurocrine Biosciences Revenue
- 2,860,500,000 USD
- Blue Owl Capital Revenue
- 2,870,178,000 USD
- Neurocrine Biosciences Operating income
- 619,100,000 USD
- Blue Owl Capital Operating income
- 627,152,000 USD